HEALTHCARE AND LIFE SCIENCES
CHANNEL DESIGN · ECONOMICS · DISTRIBUTION STRATEGY
Channel and Distribution
Channel decisions move net revenue directly, but distribution models are often selected without modeling the downstream economics. Channel strategy and payer strategy are the same decision made twice.
Specialty versus retail economics
Full economic modeling of channel choice including rebate, margin, and access implications.
Site-of-care economics
Reimbursement dynamics and channel design for injectable and infusible products.
Limited and direct distribution
Limited distribution, direct-to-pharmacy, and specialty channel design aligned to brand goals.
Institutional contracting
Group purchasing participation economics, contract structure, and competitive positioning.
Trade and rebate alignment
Distribution strategy aligned to payer and rebate goals, because the two determine each other.
Contract pharmacy economics
Network design, restriction analysis, and channel economics for manufacturers and health systems.
ACCESS STRATEGY · PROGRAM DESIGN · AFFORDABILITY
Patient Services and Affordability
Patient support programs are frequently designed in isolation from payer and distribution strategy. When that happens, the program absorbs budget without improving access — an expensive call center rather than a route to therapy.
Program design and strategy
End-to-end design from prior authorization support through onboarding and adherence.
Financial assistance design
Copay structure, patient assistance design, and affordability strategy aligned to access goals.
Operational health review
SOPs aligned to actual program performance, with test-versus-control measurement.
Partner selection and oversight
Vendor evaluation, contract structure, performance metrics, and ongoing governance.
Access integration
Patient services planned against payer, channel, and distribution strategy rather than beside it.
Program economics
Full economic modeling of program cost and exposure across copay and assistance.
COMMERCIALIZATION · ACCESS · CONTRACTING
Market Access and Payer Strategy
Manufacturers rarely see how payers and PBMs make formulary decisions beyond the rebate. Payers rarely see how manufacturers model net revenue. Most access strategies are built with only one side of that picture.
Rebate and contract strategy
Scenario modeling, rebate optimization, and contract risk scoring across payer and channel.
Payer landscape assessment
Formulary positioning, decision dynamics, and competitive access benchmarking.
Coverage sequencing
Commercial, Medicare, and Medicaid coverage strategy aligned to access and economic objectives.
Employer and self-funded design
Benefit economics, self-funded plan design, and drug cost management strategy.
Claims and point-of-sale analytics
Claims signal converted into utilization patterns, channel shift, and rebate forecasting.
Manufacturer education
How payers evaluate value and risk, and where manufacturer assumptions most often break.
GROSS-TO-NET · SCENARIO MODELING · ECONOMIC INTEGRATION
Integrated Analysis and Economic Modeling
Every commercial lever moves net revenue, and most organizations model them one at a time. The interactions between rebate strategy, channel decisions, patient programs, and benefit design are where the surprises live.
Gross-to-net modeling
Integrated modeling of rebates, fees, copay offsets, and channel economics.
Cross-lever integration
How rebate strategy, channel decisions, and program design interact across the full model.
Benefit design economics
Employer benefit economics and self-funded plan design integrated into the full picture.
Utilization and clinical economics
Utilization analytics, clinical economics modeling, and real-world evidence integration.
Hidden cost driver identification
Quantifying leakage, channel shift, rebate erosion, and program inefficiency.
Board-level reporting
Multi-lever economics translated into a dashboard a board can act on.
